338 related articles for article (PubMed ID: 31505051)
1. The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes.
Crasto W; Morrison AE; Gray LJ; John E; Jarvis J; Brela J; Khunti K; Troughton J; Lawrence IG; McNally PG; Davies MJ
Diabet Med; 2020 Feb; 37(2):286-297. PubMed ID: 31505051
[TBL] [Abstract][Full Text] [Related]
2. Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study.
Crasto W; Jarvis J; Khunti K; Skinner TC; Gray LJ; Brela J; Troughton J; Daly H; Lawrence IG; McNally PG; Carey ME; Davies MJ
Diabetes Res Clin Pract; 2011 Sep; 93(3):328-36. PubMed ID: 21640424
[TBL] [Abstract][Full Text] [Related]
3. Effects of an Electronic Software "Prompt" With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (the GP-Prompt Study): Results of a Pragmatic Cluster-Randomized Trial.
Willis A; Crasto W; Gray LJ; Dallosso H; Waheed G; Davies M; Seidu S; Khunti K
Diabetes Care; 2020 Aug; 43(8):1893-1901. PubMed ID: 32430457
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
[TBL] [Abstract][Full Text] [Related]
5. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study.
Janssen PG; Gorter KJ; Stolk RP; Rutten GE
Br J Gen Pract; 2009 Jan; 59(558):43-8. PubMed ID: 19105915
[TBL] [Abstract][Full Text] [Related]
7. Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry.
Luk AO; Li X; Zhang Y; Guo X; Jia W; Li W; Weng J; Yang W; Chan WB; Ozaki R; Tsang CC; Mukhopadhyay M; Ojha AK; Hong EG; Yoon KH; Sobrepena L; Toledo RM; Duran M; Sheu W; Q Do T; Nguyen TK; Ma RC; Kong AP; Chow CC; Tong PC; So WY; Chan JC;
Diabet Med; 2016 Sep; 33(9):1230-9. PubMed ID: 26511783
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
[TBL] [Abstract][Full Text] [Related]
9. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
Safai N; Carstensen B; Vestergaard H; Ridderstråle M
BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
[TBL] [Abstract][Full Text] [Related]
10. Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.
Usman M; Gillies CL; Khunti K; Davies MJ
Diabetes Res Clin Pract; 2018 Dec; 146():76-84. PubMed ID: 30312714
[TBL] [Abstract][Full Text] [Related]
11. Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.
Eliraqi GM; Vistisen D; Lauritzen T; Sandbaek A; Jørgensen ME; Faerch K
Diabet Med; 2015 Aug; 32(8):1085-9. PubMed ID: 25819139
[TBL] [Abstract][Full Text] [Related]
12. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
[TBL] [Abstract][Full Text] [Related]
14. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
16. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.
Minutolo R; Sasso FC; Chiodini P; Cianciaruso B; Carbonara O; Zamboli P; Tirino G; Pota A; Torella R; Conte G; De Nicola L
J Hypertens; 2006 Aug; 24(8):1655-61. PubMed ID: 16877970
[TBL] [Abstract][Full Text] [Related]
17. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
[TBL] [Abstract][Full Text] [Related]
18. Intensive multifactorial intervention improved renal impairment in short-duration type 2 diabetes: A randomized, controlled, 7-year follow-up trial.
Shi C; Fang X; Yang Y; Bai R; Yu S; Sun G; Song G; Du J
J Diabetes Complications; 2020 Jan; 34(1):107468. PubMed ID: 31761418
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients - design of a randomised controlled trial ('TRIGGER study').
Boels AM; Rutten G; Zuithoff N; de Wit A; Vos R
BMC Endocr Disord; 2018 Oct; 18(1):74. PubMed ID: 30348142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
